These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24554065)

  • 21. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
    Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
    Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
    Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V
    Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of periostin in the liver metastasis of colorectal cancer.
    Wu G; Wang X; Zhang X
    Cancer Biother Radiopharm; 2013 May; 28(4):298-302. PubMed ID: 23347152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma.
    Vilchez V; Turcios L; Zaytseva Y; Stewart R; Lee EY; Maynard E; Shah MB; Daily MF; Tzeng CW; Davenport D; Castellanos AL; Krohmer S; Hosein PJ; Evers BM; Gedaly R
    Am J Surg; 2016 Aug; 212(2):238-45. PubMed ID: 27033253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
    Horst D; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
    Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
    J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
    Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
    Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of expression of CD133 and Ki-67 in gastric cancer.
    Saricanbaz I; Karahacioglu E; Ekinci O; Bora H; Kilic D; Akmansu M
    Asian Pac J Cancer Prev; 2014; 15(19):8215-9. PubMed ID: 25339008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AC133 expression associated with poor prognosis in stage II colorectal cancer.
    Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
    Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Spelt L; Sasor A; Ansari D; Hilmersson KS; Andersson R
    Anticancer Res; 2018 Jan; 38(1):313-320. PubMed ID: 29277789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
    Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
    World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
    Jiang S; Pei L; Yang ZL; Liu G
    Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Peng Z; Hu J; Li Y; Mo X; Zhou Z
    Oncotarget; 2016 Nov; 7(47):77389-77403. PubMed ID: 27764803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in hepatic metastases of colorectal carcinoma: immunohistochemical analysis of tumor biological factors.
    Nanashima A; Yamaguchi H; Sawai T; Yamaguchi E; Kidogawa H; Matsuo S; Yasutake T; Tsuji T; Jibiki M; Nakagoe T; Ayabe H
    Dig Dis Sci; 2001 Aug; 46(8):1623-8. PubMed ID: 11508659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.
    Liu BL; Liu SJ; Baskys A; Cheng H; Han Y; Xie C; Song H; Li J; Xin XY
    BMC Cancer; 2014 Nov; 14():829. PubMed ID: 25399490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical features of CD133 expression: association with resistance to chemoradiotherapy in rectal cancer.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Kawamoto A; Yasuda H; Morimoto Y; Fujikawa H; Inoue Y; Miki C; Kusunoki M
    Oncol Rep; 2010 Aug; 24(2):345-50. PubMed ID: 20596619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44 is of functional importance for colorectal cancer stem cells.
    Du L; Wang H; He L; Zhang J; Ni B; Wang X; Jin H; Cahuzac N; Mehrpour M; Lu Y; Chen Q
    Clin Cancer Res; 2008 Nov; 14(21):6751-60. PubMed ID: 18980968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.